Orchid BioSciences has appointed Warren Meltzer to vice president of legal affairs and general counsel. Meltzer will also serve as corporate secretary. Meltzer will oversee all of Orchid’s legal matters. Before joining Orchid, Meltzer operated his own legal practice. From 1997 to 2002, Meltzer worked for Covance, where he last served as associate general counsel and assistant secretary. Meltzer earned a JD from the University of Michigan and a BS in economics from the Wharton School of the University of Pennsylvania.
Lynx Therapeutics said this week that it had appointed Mary Schramke acting chief executive officer, effective Dec. 15. She last served as the company’s vice president of product development, to which she was appointed in 2003 from senior director of business development. Schramke holds a PhD in microbiology from Louisiana State University in Baton Rouge and a MBA from John F. Kennedy University.
Affymetrix has elected Susan Desmond-Hellmann to its board of directors, the company said this week. She is now responsible for Genentech’s medical affairs, regulatory affairs, product development, development sciences, as well as other functions, Affy said. She holds a master’s degree in epidemiology and biostatistics from the University of California at Berkeley’s School of Public Health, and an MD from the University of Nevada at Reno, the company said.